JPS61212512A - Hair tonic - Google Patents

Hair tonic

Info

Publication number
JPS61212512A
JPS61212512A JP5488785A JP5488785A JPS61212512A JP S61212512 A JPS61212512 A JP S61212512A JP 5488785 A JP5488785 A JP 5488785A JP 5488785 A JP5488785 A JP 5488785A JP S61212512 A JPS61212512 A JP S61212512A
Authority
JP
Japan
Prior art keywords
hair
melatonin
hair tonic
dht
testosterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5488785A
Other languages
Japanese (ja)
Inventor
Takashi Eda
枝 尚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP5488785A priority Critical patent/JPS61212512A/en
Publication of JPS61212512A publication Critical patent/JPS61212512A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To provide a safe and excellent hair tonic compound containing melatonin. CONSTITUTION:The objective hair tonic can be produced by compounding 0.0001-5wt%, preferably 0.001-1wt% melatonin (a pale yellowish white crystalline powder obtained as a component secreted from conarium), and if necessary, various additives (e.g. disinfectant such as hinokitiol, cationic surfactant, etc., refreshing agent such as menthol, etc., oil such as olive oil, squalane, etc., perfume, antioxidant, UV absorber, dye, ethanol, water, etc.). It is expected that the falling-off of hair can be decreased or prevented by antagonizing testosterone or 5alpha-DHT (a male hormone) or inhibiting the bonding of the hormones with receptor protein, and melatonin exhibits the antagonistic effect.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、メラトニンを配合することにより安全で且つ
優れた養毛効果をもつ養毛料を提供するものである。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention provides a hair nourishment that is safe and has an excellent hair nourishing effect by incorporating melatonin.

[従来の技術] 男性型の禿頭や脂漏などの生理学上の徴候は、男性ホル
モンの過剰蓄積に基づく男性ホルモン刺激の増大による
と言われている。毛根、皮脂腺等の器官におけるこの男
性ホルモン活性の本体は、これら標的器官においてテス
トステロンがテストステロン−5α−レダクターゼ(以
下T−5α−Rと略す)によって還元された5α−ジヒ
ドロテストステロン(以下5α−DHTと略す)である
ことが周知となってきている。
[Prior Art] Physiological symptoms such as male-pattern baldness and seborrhea are said to be due to increased stimulation of androgenic hormones based on excessive accumulation of male hormones. The main body of this androgenic hormone activity in organs such as hair roots and sebaceous glands is 5α-dihydrotestosterone (hereinafter referred to as 5α-DHT), which is produced by reducing testosterone by testosterone-5α-reductase (hereinafter referred to as T-5α-R) in these target organs. ) is becoming well known.

即ち、畢丸や副腎で作られたテストステロンは血流にの
って皮脂腺や毛包の細胞の中にあるT−5α−Rによっ
てより強力な男性ホルモンである5α−DHTに変換さ
れる。この5α−DHTは細胞内の受容体と結合し、核
に働いて皮脂腺細胞では細胞の増殖を促す一方、毛母の
細胞に働き毛球部の毛母細胞の分裂を抑制し、毛の成長
を妨げるものとされている。
That is, testosterone produced by the tsubamaru and adrenal glands is transferred to the bloodstream and converted into 5α-DHT, a more powerful male hormone, by T-5α-R in the cells of the sebaceous glands and hair follicles. This 5α-DHT binds to intracellular receptors and acts on the nucleus to promote cell proliferation in sebaceous gland cells, while acting on hair matrix cells to suppress the division of hair matrix cells in the hair bulb, resulting in hair growth. is considered to be a hindrance.

[発明が解決しようとする問題点コ 男性型の禿や脱毛などの徴候は、テストステロンもしく
は5α−DHTと拮抗もしくは、受容体タンパクとの結
合を阻害することにより、低減または防止することがで
きると考えられ、この観点に基づいてこれまでにいくつ
かの物質が見い出されている。しかし、これらの物質は
好ましくない副作用があったり、あるいは実質上の養毛
効果に劣るという欠点があった。
[Problems to be solved by the invention] Symptoms such as male pattern baldness and hair loss can be reduced or prevented by antagonizing testosterone or 5α-DHT or inhibiting its binding to receptor proteins. Based on this viewpoint, several substances have been discovered so far. However, these substances have disadvantages in that they have undesirable side effects or are inferior in substantial hair growth effects.

一方、メラトニンは、1950年代の後半、Lerne
rらのグループによって、松果体分泌成分として発見さ
れ、内分泌諸器官や種々のホルモンとの相関をもつ物質
として、知られてきている。メラトニンの作用として、
視床下部に作用し、性腺刺激ホルモン(ゴナドトロピン
)放出因子の生合成や分泌に対して抑制的に働くものと
され、さらに、メラトニンは、各種ホルモンに対しても
抑制的に働くものとされている。本発明者らは、このメ
ラトニンの抗ホルモン作用に着目し、皮脂腺細胞もしく
は、毛母細胞に於るテストステロンもしくは5α−DH
Tに対する作用について鋭意研究を重ねた結果、メラト
ニンが局所に於てテストステロンおよび5α−DHTに
対し、直接的な拮抗作用を有することを見い出し、その
結果、安全でかつ優れた養毛効果をもつ養毛料を完成す
るに至った。
On the other hand, melatonin was developed in the late 1950s by Lerne
It was discovered as a component secreted by the pineal gland by the group of Dr. As a function of melatonin,
It acts on the hypothalamus and is said to suppress the biosynthesis and secretion of gonadotropin-releasing factors, and melatonin is also said to suppress various hormones. . The present inventors focused on the antihormonal effect of melatonin, and determined that testosterone or 5α-DH in sebaceous gland cells or hair matrix cells.
As a result of extensive research into the effect on T, we discovered that melatonin has a direct antagonistic effect on testosterone and 5α-DHT locally. We have now completed the hair dye.

[問題点を解決するための手段] すなわち本発明は、メラトニンを配合することを特徴と
する養毛料である。
[Means for Solving the Problems] That is, the present invention is a hair nourishment characterized by containing melatonin.

以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.

本発明に用いられるメラトニン(melatonin 
)は、化学名をN−acetyl  5−methox
ytrypta−n+ineといい、淡黄白色の結晶性
粉末である。
Melatonin used in the present invention
) has the chemical name N-acetyl 5-methox
It is called ytrypta-n+ine and is a pale yellowish white crystalline powder.

メラトニンの配合量は、本発明の養毛料中o、oooi
〜5重量%、好ましくはo、ooi〜1重量%とするこ
とが望ましい。
The blending amount of melatonin is o, oooi in the hair nourishment of the present invention.
It is desirable to set it to 5 weight%, preferably o,ooi to 1 weight%.

本発明に係る養毛料には、メラトニンのほか通常養毛料
に用いられる添加剤、たとえば、ヒノキチオール、カチ
オン界面活性剤等の殺菌剤、メントール等の清涼剤、オ
リーブ油、スクワラン、高級アルコール等の油分、その
他界面活性剤、香料、酸化防止剤、紫外線吸収剤、色素
、エタノール、水等を配合することができる。
In addition to melatonin, the hair care product of the present invention includes additives commonly used in hair care products, such as bactericidal agents such as hinokitiol and cationic surfactants, cooling agents such as menthol, oils such as olive oil, squalane, and higher alcohols, In addition, surfactants, fragrances, antioxidants, ultraviolet absorbers, pigments, ethanol, water, etc. can be added.

次に本発明に用いるメラトニンの受容体タンパクと5α
−DHTとの競合的拮抗作用について比較例をあげて説
明する。
Next, melatonin receptor protein and 5α used in the present invention
-Competitive antagonism with DHT will be explained using comparative examples.

受容体タンパクと5α−DHTとの競合的拮抗作用Ta
kayasuらの方法(Arch、 Dermatol
、 Res。
Competitive antagonism between receptor protein and 5α-DHT Ta
Kayasu et al.'s method (Arch, Dermatol
, Res.

264、50−51.1979)に基づき、受容体タン
パクと5α−DHTとの結合量を測定した。実験に供し
た試料濃度は10−6  モル濃度である。得られたデ
ータから次式を用いて競合的拮抗阻害率を求めた。結果
を表1に示す。
264, 50-51.1979), the amount of binding between the receptor protein and 5α-DHT was measured. The sample concentration used in the experiment was 10-6 molar. Competitive competitive inhibition rate was calculated from the obtained data using the following formula. The results are shown in Table 1.

阻害率(%)−(C−t/C)XLOOC:コントロー
ルの受容体タンパクと 5α−DHTとの結合量 t:試料を添加した時の受容体タンパ クと5α−D)ITとの結合量 表1から明らかなように、メラトニンは、従来公知のエ
チニルエストラジオールに比べ、受容体タンパクと5α
−DHTとの競合的拮抗作用による結合阻害効果は大で
あり、本発明の目的を達成する物質であるといえる。従
って、メラトニンを配合した本発明の養毛料の養毛効果
は大なることが期待された。
Inhibition rate (%) - (C-t/C) As is clear from 1, melatonin has a higher relationship with receptor protein and 5α compared to the conventionally known ethinyl estradiol.
It has a large binding inhibiting effect due to competitive antagonism with -DHT, and can be said to be a substance that achieves the object of the present invention. Therefore, it was expected that the hair growth agent of the present invention containing melatonin would have a greater hair growth effect.

[実施例] 次に実施例をあげて本発明をさらに詳細に説明する。本
発明はこれにより限定されるものではない。
[Example] Next, the present invention will be explained in more detail by giving examples. The present invention is not limited thereby.

養毛効果測定法 養毛料使用前後の洗髪時、脱毛本数の変化で判定した。Hair growth effect measurement method Judgment was made based on the change in the number of strands of hair removed when washing the hair before and after using the hair tonic.

被験者は実施例1〜3および比較例1の計4種類の各々
の群ごとに10名とした。測定期間は、4ケ月間とし、
最初の2ケ月間は養毛料無塗布の期間、後半の2ケ月間
を養毛料塗布の期間とし、この間、2日おきに洗髪し、
1週間に1変復毛を回収しその本数を数えた。各期間の
夫子本数の表示は、養毛料無塗布の2ケ月間、計8回の
抜毛本数のデータと養毛料塗布の2ケ月間、計8回の抜
毛本数のデータを夫々の期間ごとにまとめ、平均値+α
の形で1回当りの抜毛本数として表示した。単位は本で
ある。効果の判定は、夫々の期間の平均値の差から次の
ように表示した。
There were 10 subjects in each of the four groups of Examples 1 to 3 and Comparative Example 1. The measurement period was 4 months.
The first two months are a period of no hair growth, and the latter two months are a period of hair growth, during which you wash your hair every two days.
Hairs were collected once a week and their number was counted. The number of hairs pulled out for each period is summarized by data on the number of hairs pulled out for a total of 8 times during the 2 months without hair tonic application, and data on the number of hairs pulled out for a total of 8 times during the 2 months when hair tonics were applied, for each period. , average value + α
It was expressed as the number of hairs pulled per session. The unit is a book. The effectiveness was determined based on the difference between the average values for each period as shown below.

什:抜毛本数が70本以上減っており著しい効果を認め
た。
However, the number of hairs pulled was reduced by more than 70, indicating a significant effect.

+:抜毛木数が40本以上減っておりかなりの効果を認
めた。
+: The number of hair-pulled trees decreased by 40 or more, and a considerable effect was recognized.

±:抜毛木数が10本以上減っておりやや効果ありとい
えた。
±: The number of hairs removed was reduced by 10 or more, indicating that it was somewhat effective.

:抜毛本数の減少が10本未満であり効果ありとはいえ
ない。
: The reduction in the number of hairs pulled was less than 10, so it cannot be said that there is an effect.

(以下余白) (製造法) 95%エタノールにメラトニンまたは、エチニルエスト
ラジオール、硬化ヒマシ油EO40モル付加物を添加し
、攪拌溶解させ、次いでイオン交換水を添加、混合して
養毛料を得た。
(Margin below) (Manufacturing method) Melatonin, ethinyl estradiol, and 40 mole adduct of hydrogenated castor oil EO were added to 95% ethanol, stirred and dissolved, and then ion-exchanged water was added and mixed to obtain a hair nourishing agent.

(以下余白) この結果から明らかなようにメラトニン配合の本発明に
係る養毛材は従来公知のエチニルエストラジオールを配
合した養毛材に比較して、養毛効果が優れているといえ
る。
(The following is a blank space) As is clear from these results, it can be said that the hair nourishing material according to the present invention containing melatonin has a superior hair nourishing effect compared to the hair nourishing material containing conventionally known ethinyl estradiol.

〔実施例4〕養毛料 エタノール55.0gにポリオキシエチレン(8モル)
オレイルアルコールエーテル2.0g、メラトニン0.
05g 、ヒノキチオール0.05gを加え、これに香
料、染料を夫々通量加えて溶解したのち、イオン交換水
42.45gを加えて可溶化し養毛材を得た。
[Example 4] Polyoxyethylene (8 mol) in 55.0 g of hair nourishing ethanol
Oleyl alcohol ether 2.0g, melatonin 0.
After adding 0.05 g of hinokitiol and 0.05 g of hinokitiol and dissolving the perfume and dye, 42.45 g of ion-exchanged water was added and solubilized to obtain a hair nourishing material.

〔実施例5〕 メラトニン0.5g、ポリオキシエチレン(60モル)
硬化ヒマシ油2.Og、グリセリン10.0g、ジプロ
ピレングリコール10.0gおよび1.3−ブチレング
リコール5.Ogと5.0gのポリエチレングリコール
1500とを60℃で加熱溶解する(A部)。セチルイ
ソオクタノエート10.0g 。
[Example 5] Melatonin 0.5g, polyoxyethylene (60 mol)
Hydrogenated castor oil2. Og, glycerin 10.0 g, dipropylene glycol 10.0 g and 1.3-butylene glycol5. Og and 5.0 g of polyethylene glycol 1500 are heated and dissolved at 60° C. (Part A). Cetyl isooctanoate 10.0g.

スクワラン5.0g 、ワセリン2.0gおよびプロピ
ルパラベン2.0gを60℃で加熱溶解する(B部)。
5.0 g of squalane, 2.0 g of petrolatum, and 2.0 g of propylparaben are heated and dissolved at 60°C (Part B).

カルボキシビニルポリマー1%水溶液30.0gおよび
ヘキサメタリン酸ソーダ0.03gをイオン交換水8.
35gに溶解する(0部)。A部とB部とを60℃にて
混合し、ホモミキサー処理しゲルを作る。これにイオン
交換水0.5gを徐々に添加し、ホモミキサーで分散す
る。次にこれに0部を加え、最後にカセイカリ0.12
gをイオン交換水5.0gに溶かした水溶液を添加しホ
モミキサーで乳化して0/−乳液型養毛材を得た。
8. Add 30.0 g of a 1% aqueous solution of carboxyvinyl polymer and 0.03 g of sodium hexametaphosphate to ion-exchanged water.
Dissolve in 35g (0 parts). Part A and Part B are mixed at 60°C and treated with a homomixer to form a gel. Gradually add 0.5 g of ion-exchanged water to this and disperse with a homomixer. Next, add 0 parts to this, and finally add 0.12 parts of caustic potash.
An aqueous solution prepared by dissolving 5.0 g of ion-exchanged water was added and emulsified using a homomixer to obtain a 0/- emulsion type hair nourishing material.

〔実施例6〕 流動パラフィン5.0g 、セトステアリルアルコール
5.5g、ワセリン5.5g、グリセリルモノステアレ
ート 3.Og、ポリオキシエチレン(20モル)2−
オクチルドデシルエーテル3.0g1ビタミンEアセテ
ート0.05g 、プロピルパラベン0.3gおよび香
料0.05gを加熱溶解、混合する。これにメラトニン
0.5g、グリセリン7.0g、ジプロピレングリコー
ル20.Og、 5.0 gのポリエチレングリコール
4000、ヘキサメタリン酸ソーダ0.005gおよび
イオン交換水45.095gの加熱溶解混合物を添加し
、ホモミキサーにて乳化してクリーム状養毛料を得た。
[Example 6] Liquid paraffin 5.0g, cetostearyl alcohol 5.5g, petrolatum 5.5g, glyceryl monostearate 3. Og, polyoxyethylene (20 mol) 2-
3.0 g of octyl dodecyl ether, 0.05 g of vitamin E acetate, 0.3 g of propylparaben, and 0.05 g of fragrance are heated and dissolved and mixed. Add to this 0.5 g of melatonin, 7.0 g of glycerin, and 20 g of dipropylene glycol. A heated and dissolved mixture of Og, 5.0 g of polyethylene glycol 4000, 0.005 g of sodium hexametaphosphate, and 45.095 g of ion-exchanged water was added and emulsified with a homomixer to obtain a cream-like hair nourishment.

Claims (1)

【特許請求の範囲】[Claims] メラトニンを配合することを特徴とする養毛料Hair nourishing agent characterized by containing melatonin
JP5488785A 1985-03-19 1985-03-19 Hair tonic Pending JPS61212512A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5488785A JPS61212512A (en) 1985-03-19 1985-03-19 Hair tonic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5488785A JPS61212512A (en) 1985-03-19 1985-03-19 Hair tonic

Publications (1)

Publication Number Publication Date
JPS61212512A true JPS61212512A (en) 1986-09-20

Family

ID=12983097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5488785A Pending JPS61212512A (en) 1985-03-19 1985-03-19 Hair tonic

Country Status (1)

Country Link
JP (1) JPS61212512A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0578620A1 (en) * 1992-06-24 1994-01-12 I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi Pharmaceutical compositions for transdermal delivery of melatonin and/or its analogues
FR2741802A1 (en) * 1995-12-04 1997-06-06 Oreal Use of melatonin and its analogues to treat sensitive skin
ES2101660A1 (en) * 1995-12-21 1997-07-01 Soler Armando Jose Yanez New hair restorative for topical use.
WO1998005298A1 (en) * 1996-08-02 1998-02-12 Universidad De Granada Development of cosmetic products for human use and based on melatonine as active principle
EP0835652A1 (en) * 1996-10-10 1998-04-15 L'oreal Use of at least one glycol in the solubilisation of melatonin in water and compositions containing them
JP2004500353A (en) * 1999-11-30 2004-01-08 アサト アクチェンゲゼルシャフト アプライド サイエンス アンド テクノロジー Use of melatonin for the treatment of androgenic and chronic alopecia
ES2209649A1 (en) * 2002-12-09 2004-06-16 Carlos Arana Molina (Titular Al 25%) Oral hygiene product for human and animal use with a melatonin base as an active product
WO2004058250A1 (en) * 2002-12-31 2004-07-15 Antonio Cutando Soriano Bone regeneration product for human and veterinary use, containing melatonin as active principle
JP2006513255A (en) * 2002-10-30 2006-04-20 アサト アクチェンゲゼルシャフト アプライド サイエンス アンド テクノロジー Preparations containing melatonin, ginkgo and biotin
WO2016122172A1 (en) * 2015-01-30 2016-08-04 현대약품 주식회사 Composition for hair health or hair growth promotion, having improved stability and containing melatonin

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0578620A1 (en) * 1992-06-24 1994-01-12 I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi Pharmaceutical compositions for transdermal delivery of melatonin and/or its analogues
FR2741802A1 (en) * 1995-12-04 1997-06-06 Oreal Use of melatonin and its analogues to treat sensitive skin
ES2101660A1 (en) * 1995-12-21 1997-07-01 Soler Armando Jose Yanez New hair restorative for topical use.
WO1998005298A1 (en) * 1996-08-02 1998-02-12 Universidad De Granada Development of cosmetic products for human use and based on melatonine as active principle
EP0835652A1 (en) * 1996-10-10 1998-04-15 L'oreal Use of at least one glycol in the solubilisation of melatonin in water and compositions containing them
FR2754454A1 (en) * 1996-10-10 1998-04-17 Oreal USE OF AT LEAST ONE GLYCOL AS A SOLUBILIZING AGENT FOR MELATONIN IN WATER AND COMPOSITIONS OBTAINED
JP2004500353A (en) * 1999-11-30 2004-01-08 アサト アクチェンゲゼルシャフト アプライド サイエンス アンド テクノロジー Use of melatonin for the treatment of androgenic and chronic alopecia
JP4713805B2 (en) * 1999-11-30 2011-06-29 アサト アクチェンゲゼルシャフト アプライド サイエンス アンド テクノロジー Use of melatonin for the treatment of androgenic and diffuse alopecia
JP2006513255A (en) * 2002-10-30 2006-04-20 アサト アクチェンゲゼルシャフト アプライド サイエンス アンド テクノロジー Preparations containing melatonin, ginkgo and biotin
ES2209649A1 (en) * 2002-12-09 2004-06-16 Carlos Arana Molina (Titular Al 25%) Oral hygiene product for human and animal use with a melatonin base as an active product
WO2004058250A1 (en) * 2002-12-31 2004-07-15 Antonio Cutando Soriano Bone regeneration product for human and veterinary use, containing melatonin as active principle
WO2016122172A1 (en) * 2015-01-30 2016-08-04 현대약품 주식회사 Composition for hair health or hair growth promotion, having improved stability and containing melatonin
CN107205908A (en) * 2015-01-30 2017-09-26 现代药品株式会社 What stability was improved educates hair, hair care or hair tonic composition for promoting containing melatonin
CN107205908B (en) * 2015-01-30 2020-03-10 现代药品株式会社 Melatonin-containing composition with improved stability for promoting hair growth, nourishing hair or promoting hair growth

Similar Documents

Publication Publication Date Title
AU726833B2 (en) Compositions containing an antifungal and a cationic agent
US5470876A (en) Topical sod for treating hair loss
HUP9900581A2 (en) Composition containing an antifungal and a sulfur compound for hair and personal care and process for its preparation
JPS61212512A (en) Hair tonic
JPS6360910A (en) Skin drug for external use
JPS6127914A (en) Cosmetic
US4728667A (en) Hair treatment composition for prevention of dandruff in hair
JPH01275516A (en) Dandruff-preventive agent and hair-cosmetic
JP2566792B2 (en) Hair growth and hair growth promoter
JPS62132810A (en) Cosmetic
JPH027290B2 (en)
JPH0577647B2 (en)
JPH0481563B2 (en)
JPS6284016A (en) Hair tonic
JPS63119413A (en) Hair cosmetic
JPS6284012A (en) Hair tonic
JPS5988407A (en) Hair tonic
JPS5959607A (en) Hair tonic
JPS62169717A (en) Hair cosmetic
JP2000281557A (en) Bleaching ingredient
JPS59184114A (en) Hair tonic
JPS6054310A (en) Cosmetic
JPS60136505A (en) Cosmetic
JPS5988408A (en) Hair tonic
JPS5988409A (en) Hair tonic